Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
Year: 2014
Type: review
Abstract: Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense against multidrug-resistant Gram-negative organisms. Over the last decade, carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a significant public health threat. This review summarizes the molecular genetics, natural history, and epidemiology of CRE and discusses approaches to prevention and treatment.
DOI: 10.1111/nyas.12537
Institutions: Tel Aviv Sourasky Medical Center, Tel Aviv University
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2151487356
